Clinical Trials Browser

Interventional × Lymphoma × Hydroxyurea × Clear all

NCT00002940 2012-10-19

Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

Phase 2 Completed

Lymphoma